T2 biosystems, inc. (TTOO)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14
Cash flows from operating activities
Net loss

-58,808

-59,006

-60,114

-56,710

-53,387

-51,153

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss

-

-

-

-

-

-

-

-

-

-

-

0

-56,081

-

-52,287

-51,148

-48,097

-45,290

-42,333

-38,781

-35,089

-31,390

0

0

0

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization

2,097

2,197

2,281

2,397

2,420

2,449

2,608

2,732

2,875

2,940

2,848

2,644

2,445

2,280

2,112

1,933

1,741

1,465

1,211

992

800

691

0

0

0

Non-cash lease expense

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Stock-based compensation expense

4,585

5,458

6,885

7,928

10,549

9,897

8,471

7,519

5,014

4,790

4,995

4,871

4,715

4,848

4,928

5,118

4,736

4,168

3,495

2,725

2,136

1,653

0

0

0

Change in fair value of derivative instrument

-89

-283

-540

-624

-129

96

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Impairment of property and equipment

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash interest expense

2,460

2,407

2,321

2,243

2,224

2,216

2,400

2,546

2,631

2,710

2,073

1,547

1,055

564

525

482

478

354

298

271

125

112

0

0

0

Change in fair value of warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1

0

0

0

Deferred rent

-

-

-

-

-

217

182

147

114

115

158

201

243

250

220

175

161

119

96

49

19

-5

0

0

0

Changes in operating assets and liabilities:
Accounts receivable

681

1,039

-161

-414

1,191

1,319

1,292

612

173

140

63

693

49

-42

1

-101

272

168

0

0

0

-

-

-

-

Prepaid expenses and other assets

-25

98

-107

-151

1,116

570

1,258

194

-381

-125

-315

-17

-13

-68

-100

-19

256

-190

344

762

775

1,217

0

0

0

Inventories

-72

914

1,362

1,959

1,294

1,089

850

-90

360

110

-83

-420

-770

120

280

867

1,007

568

0

0

0

-

-

-

-

Accounts payable

1,065

2,960

2,844

1,614

-137

121

-385

-488

-381

-314

102

686

-541

-61

-213

-699

418

177

277

900

137

-208

0

0

0

Accrued expenses and other liabilities

2,325

3,708

1,742

2,086

521

-279

-408

-200

536

724

144

122

50

580

754

884

805

260

598

500

1,123

2,405

0

0

0

Deferred revenue

-529

-499

-166

-267

-89

-807

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating lease liabilities

-2,103

-2,260

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

-

-

-

-

-

-

-

-

-

-

-

0

390

-

-381

-508

-292

2,066

0

0

0

-

-

-

-

Net cash used in operating activities

-47,234

-45,361

-44,930

-41,489

-41,263

-40,138

-41,527

-43,095

-46,702

-47,718

-46,940

-46,634

-47,364

-46,442

0

0

0

-

-

-

-

-

-

-

-

Cash flows from investing activities
Net cash used in operating activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-37,130

-33,385

-29,787

-28,184

0

0

0

Purchases and manufacture of property and equipment

634

761

378

438

731

593

825

607

938

2,476

0

0

0

-

-

6,963

8,672

7,974

7,145

5,760

3,281

2,084

0

0

0

Net cash used in investing activities

-634

-761

-378

-438

-731

-593

-825

-607

-938

-2,476

-3,494

-4,782

-4,923

-5,487

0

0

0

-

-

-

-

-

-

-

-

Cash flows from financing activities
Net cash used in investing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-7,065

-5,680

-3,281

-2,084

0

0

0

Payment of offering costs for issuance of common stock in public offering

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

Proceeds from issuance of common stock and stock option exercises, net

-

-

-

-

-

-

0

0

724

-

999

1,031

1,056

1,018

1,372

1,416

1,730

1,804

0

0

0

-

-

-

-

Proceeds from issuance of common stock in public offering, net of offering costs

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Principal repayments of finance leases

-

882

1,335

1,393

1,539

1,547

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments of issuance costs for notes payable

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

0

-

-

-

-

-

-

-

-

Principal repayments of note payable

-

-

-

-

-

-

-

-

-

-

30,821

32,632

32,623

32,404

2,555

549

314

309

306

3,297

3,666

4,037

0

0

0

Net cash provided by (used in) financing activities

46,791

6,350

1,296

-361

49,661

49,657

49,600

68,198

18,471

18,505

28,220

47,332

51,590

51,755

0

0

0

-

-

-

-

-

-

-

-

Net increase (decrease) in cash, cash equivalents and restricted cash

-1,077

-39,772

-44,012

-42,288

7,667

8,926

7,248

24,496

-29,169

-31,689

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Reconciliation of cash, cash equivalents and restricted cash at end of period
Net cash provided by financing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

8,723

76,478

74,665

73,919

0

0

0

Net decrease in cash and cash equivalents

-

-

-

-

-

-

-

-

-

-

-

-

-

-

34,994

-3,071

-5,776

-187

-35,472

37,413

41,597

43,651

0

0

0

Supplemental disclosures of cash flow information
Cash paid for interest

4,434

4,659

4,362

4,123

3,945

3,786

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash paid for interest

-

-

-

-

-

-

-

-

-

-

-

-

3,208

-

2,277

1,936

1,702

1,506

1,331

1,106

785

515

0

0

0

Supplemental disclosures of noncash activities
Transfer of T2 owned instruments and components to (from) inventory

667

-8

-527

-1,017

-712

244

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of warrants issued and modified

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Transfer of T2 owned instruments and components to inventory

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Leasehold improvements paid by landlord

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

Right-of-use assets obtained in exchange for new operating lease liabilities

-

4,805

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchases of property and equipment included in accounts payable and accrued expenses

101

107

14

172

17

80

208

239

247

189

39

-51

11

82

-1,187

-1,164

47

247

0

0

0

-

-

-

-

Accretion of Series A-1, A-2, B, C, D and E redeemable convertible preferred stock to redemption value

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0